Arnold C. Hanish, Director at Salarius Pharmaceuticals, Inc. (SLRX), bought 3,000 shares at $3.59 ($11K) on 2019-11-25, disclosed to the SEC on 2019-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SLRX | BUY | 2025-11-24 | $4K | — | Filing → |
| OMER | SELL | 2023-05-23 | $32K | — | Filing → |
| SLRX | BUY | 2022-06-06 | $5K | — | Filing → |